These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 24222125)
21. PAX-2 is a helpful marker for diagnosing metastatic renal cell carcinoma: comparison with the renal cell carcinoma marker antigen and kidney-specific cadherin. Ozcan A; Zhai Q; Javed R; Shen SS; Coffey D; Krishnan B; Truong LD Arch Pathol Lab Med; 2010 Aug; 134(8):1121-9. PubMed ID: 20670131 [TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma. Ohno Y; Izumi M; Yoshioka K; Ohori M; Yonou H; Tachibana M Oncol Rep; 2008 Sep; 20(3):511-6. PubMed ID: 18695899 [TBL] [Abstract][Full Text] [Related]
23. Eight proteins play critical roles in RCC with bone metastasis via mitochondrial dysfunction. Wang J; Zhao X; Qi J; Yang C; Cheng H; Ren Y; Huang L Clin Exp Metastasis; 2015 Aug; 32(6):605-22. PubMed ID: 26115722 [TBL] [Abstract][Full Text] [Related]
24. Laminin alpha1 chain in human renal cell carcinomas and integrin-mediated adhesion of renal cell carcinoma cells to human laminin isoforms. Rissanen J; Korhonen M; Lehto VP; Virtanen I J Pathol; 2003 Jun; 200(2):157-67. PubMed ID: 12754736 [TBL] [Abstract][Full Text] [Related]
25. Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid change. Dhillon J; Amin MB; Selbs E; Turi GK; Paner GP; Reuter VE Am J Surg Pathol; 2009 Jan; 33(1):44-9. PubMed ID: 18941398 [TBL] [Abstract][Full Text] [Related]
26. Sarcomatoid renal cell carcinoma in a young adult. Kourda N; Zeddini A; Zaafrani MR; Zermani R; Ferchichi L; Ayed M; Jilani SB Pathologica; 2006 Jun; 98(3):181-3. PubMed ID: 17036947 [TBL] [Abstract][Full Text] [Related]
27. Sperm-associated antigen 9 is associated with tumor growth, migration, and invasion in renal cell carcinoma. Garg M; Kanojia D; Khosla A; Dudha N; Sati S; Chaurasiya D; Jagadish N; Seth A; Kumar R; Gupta S; Gupta A; Lohiya NK; Suri A Cancer Res; 2008 Oct; 68(20):8240-8. PubMed ID: 18922895 [TBL] [Abstract][Full Text] [Related]
28. Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma. Zhang T; Zheng J; Jiang N; Wang G; Shi Q; Liu C; Lu Y Cancer Lett; 2009 Sep; 283(1):59-67. PubMed ID: 19380190 [TBL] [Abstract][Full Text] [Related]
29. BMP-2 inhibits tumor growth of human renal cell carcinoma and induces bone formation. Wang L; Park P; Zhang H; La Marca F; Claeson A; Than K; Rahman S; Lin CY Int J Cancer; 2012 Oct; 131(8):1941-50. PubMed ID: 22275155 [TBL] [Abstract][Full Text] [Related]
32. Flow cytometric analysis and motility response to laminin and fibronectin of four new metastatic variants of the human renal cell carcinoma line RC43. Grossi FS; Keizer DM; Saracino GA; Erkens S; Romijn JC; Schröder FH Prog Clin Biol Res; 1992; 378():195-205. PubMed ID: 1301582 [TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical distinction of renal cell carcinoma from other carcinomas with clear-cell histomorphology: utility of CD10 and CA-125 in addition to PAX-2, PAX-8, RCCma, and adipophilin. Mentrikoski MJ; Wendroth SM; Wick MR Appl Immunohistochem Mol Morphol; 2014 Oct; 22(9):635-41. PubMed ID: 25279712 [TBL] [Abstract][Full Text] [Related]
34. Spheres derived from the human SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem cells. Zhong Y; Guan K; Guo S; Zhou C; Wang D; Ma W; Zhang Y; Li C; Zhang S Cancer Lett; 2010 Dec; 299(2):150-60. PubMed ID: 20846785 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of metastatic renal cell carcinomas expressing somatostatin receptors by a targeted cytotoxic analogue of somatostatin AN-238. Plonowski A; Schally AV; Nagy A; Kiaris H; Hebert F; Halmos G Cancer Res; 2000 Jun; 60(11):2996-3001. PubMed ID: 10850448 [TBL] [Abstract][Full Text] [Related]
36. Renal cell carcinoma marker (RCC-Ma) is specific for cutaneous metastasis of renal cell carcinoma. Perna AG; Ostler DA; Ivan D; Lazar AJ; Diwan AH; Prieto VG; Reed JA J Cutan Pathol; 2007 May; 34(5):381-5. PubMed ID: 17448192 [TBL] [Abstract][Full Text] [Related]
37. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma. Morris MR; Gentle D; Abdulrahman M; Maina EN; Gupta K; Banks RE; Wiesener MS; Kishida T; Yao M; Teh B; Latif F; Maher ER Cancer Res; 2005 Jun; 65(11):4598-606. PubMed ID: 15930277 [TBL] [Abstract][Full Text] [Related]
38. Characterization of a renal cell carcinoma cell line derived from a human bone metastasis and establishment of an experimental nude mouse model. Weber KL; Pathak S; Multani AS; Price JE J Urol; 2002 Aug; 168(2):774-9. PubMed ID: 12131367 [TBL] [Abstract][Full Text] [Related]
39. Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro, inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel. Chang HR; Chen PN; Yang SF; Sun YS; Wu SW; Hung TW; Lian JD; Chu SC; Hsieh YS Mol Carcinog; 2011 Oct; 50(10):811-23. PubMed ID: 21574189 [TBL] [Abstract][Full Text] [Related]
40. Establishment of a new human epithelioid sarcoma cell line, FU-EPS-1: molecular cytogenetic characterization by use of spectral karyotyping and comparative genomic hybridization. Nishio J; Iwasaki H; Nabeshima K; Ishiguro M; Naumann S; Isayama T; Naito M; Kaneko Y; Kikuchi M; Bridge JA Int J Oncol; 2005 Aug; 27(2):361-9. PubMed ID: 16010416 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]